Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2870 | 2052 | 34.2 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1407 | 7566 | GUILLAIN BARRE SYNDROME//CASTLEMANS DISEASE//POEMS SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MULTIFOCAL MOTOR NEUROPATHY | Author keyword | 262 | 77% | 9% | 178 |
2 | CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY | Author keyword | 167 | 61% | 9% | 175 |
3 | CIDP | Author keyword | 145 | 63% | 7% | 145 |
4 | CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | Author keyword | 97 | 68% | 4% | 85 |
5 | LEWIS SUMNER SYNDROME | Author keyword | 62 | 90% | 1% | 27 |
6 | ANTI MAG ANTIBODIES | Author keyword | 32 | 88% | 1% | 15 |
7 | ANTI MAG | Author keyword | 31 | 92% | 1% | 12 |
8 | CONDUCTION BLOCK | Author keyword | 30 | 25% | 5% | 103 |
9 | TERMINAL LATENCY INDEX | Author keyword | 23 | 86% | 1% | 12 |
10 | ANTI GM1 ANTIBODIES | Author keyword | 23 | 56% | 1% | 28 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYRADICULONEUROPATHY | 346 | 69% | 14% | 293 |
2 | MULTIFOCAL MOTOR NEUROPATHY | 185 | 51% | 13% | 259 |
3 | CIDP | 167 | 72% | 6% | 131 |
4 | LEWIS SUMNER SYNDROME | 137 | 88% | 3% | 65 |
5 | PERIPHERAL NERVE SOCIETY | 119 | 76% | 4% | 84 |
6 | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | 102 | 50% | 7% | 147 |
7 | PERSISTENT CONDUCTION BLOCK | 85 | 79% | 3% | 55 |
8 | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | 83 | 40% | 8% | 161 |
9 | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | 83 | 36% | 9% | 187 |
10 | DEMYELINATING NEUROPATHY | 67 | 46% | 5% | 108 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 12 | 14% | 4% | 79 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pathogenesis of immune-mediated neuropathies | 2015 | 3 | 76 | 66% |
Medical progress: Chronic inflammatory demyelinating polyneuropathy | 2005 | 180 | 100 | 74% |
Advances in the diagnosis, pathogenesis and treatment of CIDP | 2011 | 39 | 115 | 87% |
Clinical spectrum of chronic acquired demyelinating polyneuropathies | 2001 | 235 | 111 | 95% |
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype | 2015 | 2 | 158 | 58% |
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition | 2010 | 63 | 137 | 87% |
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies | 2012 | 28 | 128 | 80% |
Multifocal motor neuropathy: Current concepts and controversies | 2005 | 107 | 147 | 67% |
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature | 2011 | 23 | 10 | 80% |
OPTIMIZING IGG THERAPY IN CHRONIC AUTOIMMUNE NEUROPATHIES: A HYPOTHESIS DRIVEN APPROACH | 2015 | 1 | 116 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IRCCS HUMANITAS CLIN | 15 | 63% | 0.7% | 15 |
2 | GIORGIO SPAGNOL SERV CLIN NEUROIMMUNOL | 10 | 73% | 0.4% | 8 |
3 | PERIPHERAL NEUROPATHY | 9 | 28% | 1.4% | 28 |
4 | REFERENCE MALAD NEUROMUSCULAI RA | 8 | 70% | 0.3% | 7 |
5 | NEUROMUSCULAR CLIN | 4 | 22% | 0.8% | 17 |
6 | CLIN NEUROLDINO FERRARI | 4 | 75% | 0.1% | 3 |
7 | GNPS | 3 | 100% | 0.1% | 3 |
8 | HOSP UNIV NEUROSCI | 3 | 100% | 0.1% | 3 |
9 | REFERENCE RARE NEUROMUSCULAR DIS | 3 | 100% | 0.1% | 3 |
10 | REFERENCE MALAD NEUROMUSCULAI ENFANT ADU | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233159 | GUILLAIN BARRE SYNDROME//MILLER FISHER SYNDROME//ACUTE MOTOR AXONAL NEUROPATHY |
2 | 0.0000183604 | POEMS SYNDROME//CROW FUKASE SYNDROME//OSTEOSCLEROTIC MYELOMA |
3 | 0.0000176000 | DIABETIC AMYOTROPHY//DIABETIC NEUROPATHIC CACHEXIA//LUMBOSACRAL PLEXUS NEUROPATHY |
4 | 0.0000174202 | EPENDYMIN//HNK 1 CARBOHYDRATE//GLUCURONYLTRANSFERASE |
5 | 0.0000138753 | EXPERIMENTAL AUTOIMMUNE NEURITIS//EXPERIMENTAL ALLERGIC NEURITIS//EXPERIMENTAL AUTOIMMUNE NEURITIS EAN |
6 | 0.0000137390 | MYELIN ASSOCIATED GLYCOPROTEIN//L MAG//CEREBELLAR SOLUBLE LECTIN |
7 | 0.0000133160 | NEUROLYMPHOMATOSIS//NEUROLEUKEMIOSIS//PERIPHERAL NERVE LYMPHOMA |
8 | 0.0000093710 | SANATORIUM CHIBA//ALS TREATMENT//BRAIN CORTEX SYNAPTOSOMES |
9 | 0.0000090087 | F WAVES//F WAVE//LUMBOSACRAL RADICULOPATHY |
10 | 0.0000082415 | INTRAVENOUS IMMUNOGLOBULIN//IVIG//INTRAVENOUS IMMUNOGLOBULINS |